Searched for
EREZ VIGODMAN
Intas eyes Teva’s oncology, women’s health divisions in EuropeTeva, the world’s largest maker of generic drugs, plans to divest some assets including its global women’s health and European cancer and p...- Teva appoints Dipankar Bhattacharjee as Prez, CEO Global Generic GroupAs President and CEO of Teva Generics Europe, Bhattacharjee has a proven track record of improving revenues and profitability, significantl...
- Teva-Allergan deal a booster for Indian companiesTeva Pharmaceutical Industries’ $40.5-billion purchase of Allergan’s generics business may help Indian generic-drug makers acquire products
- Mylan rejects Teva's $40 billion merger offer as undervaluedDrug major Mylan has rejected a $40 billion unsolicited merger offer from Israel's Teva Pharmaceutical Industries calling the bid undervalu...
- Teva offers to buy Mylan for $40.1 billionTeva, the world’s biggest maker of generic medicines, offered $82 a share in cash and stock for Mylan, according to a statement.
- Setback to Natco pharma; US Supreme Court sends Teva patent case to Federal CircuitThe US Supreme Court has sent back the patent case related to Teva's multiple sclerosis drug Copaxone for a review by the Federal Circuit.
Load More